A multi-center, observational study to characterize the clinical course in a real world, US cohort of patients with relapsing Multiple Sclerosis of advanced age (>50 years) treated with Cladribine tablets (AGING Study).
Sponsor: EMD Serono
To learn more about the trial, call the Reading Hospital Research Office at 484-628-8585.
